Ignite Creation Date:
2025-12-25 @ 2:49 AM
Ignite Modification Date:
2025-12-31 @ 9:29 PM
Study NCT ID:
NCT03452033
Status:
COMPLETED
Last Update Posted:
2022-07-12
First Post:
2018-02-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
H-1337 Ophthalmic Solution Phase 1/2
Sponsor:
Allysta Pharmaceutical
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ALY337-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None